Cargando…

Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study

BACKGROUND: Elective treatment of lymph nodes in oropharyngeal cancer (OPC) has impact on both regional recurrences (RR) and risk of late side effects. This study was performed to quantify the dose-dependent impact on RR and overall survival (OS) in a prospectively collected cohort of OPC from the A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Söderström, Karin, Nilsson, Per, Dalianis, Tina, Kjellén, Elisabeth, Zackrisson, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490759/ https://www.ncbi.nlm.nih.gov/pubmed/26014350 http://dx.doi.org/10.1186/s13014-015-0422-8

Ejemplares similares

Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study
por: Ottosson, Sandra, et al.
Publicado: (2014)

Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy
por: Ottosson, Sandra, et al.
Publicado: (2013)

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
por: Adrian, Gabriel, et al.
Publicado: (2022)

Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2019)

Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010)

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
por: Chen, Xingming, et al.
Publicado: (2016)

Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy
por: DALIANIS, TINA
Publicado: (2014)

Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
por: Stern, Peter L., et al.
Publicado: (2021)

What's new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice?
por: Berthelsen, Anne Kiil, et al.
Publicado: (2007)

GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy
por: Sun, Peng, et al.
Publicado: (2023)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
por: Jóhannesson, Vilberg, et al.
Publicado: (2021)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
por: Haeggblom, Linnea, et al.
Publicado: (2017)

Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
por: Rasmusson, Elisabeth, et al.
Publicado: (2020)

A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy
por: Garcia, Darwin A., et al.
Publicado: (2023)

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
por: Wendt, Malin, et al.
Publicado: (2021)

PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2020)

Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy
por: Sumner, Whitney A., et al.
Publicado: (2017)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer
por: Marklund, Linda, et al.
Publicado: (2012)

Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
por: Rasmusson, Elisabeth, et al.
Publicado: (2013)

The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2009)

The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy
por: Zhang, Hua, et al.
Publicado: (2018)

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
por: Panje, Cédric, et al.
Publicado: (2017)

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report
por: Tamaki, Tomoaki, et al.
Publicado: (2013)

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and (68)Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2022)

What matters to you? – Free-text comments in a questionnaire from patients undergoing radiotherapy
por: Olausson, Kristina, et al.
Publicado: (2019)

Adaptive radiotherapy based on statistical process control for oropharyngeal cancer
por: Wang, Hesheng, et al.
Publicado: (2020)

[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy
por: Ishihara, Takeaki, et al.
Publicado: (2017)

Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma
por: Lybak, Stein, et al.
Publicado: (2010)

HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome
por: Näsman, Anders, et al.
Publicado: (2013)

Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma
por: Li, Feng, et al.
Publicado: (2020)

The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
por: Zheng, Lin, et al.
Publicado: (2021)

Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions
por: Miyake, Makito, et al.
Publicado: (2019)

Development and psychometric testing of an instrument to measure the patient’s experience of external radiotherapy: The Radiotherapy Experience Questionnaire (RTEQ)
por: Olausson, Kristina, et al.
Publicado: (2017)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Special Issue “HPV in the Head and Neck Region”
por: Dalianis, Tina, et al.
Publicado: (2021)

External beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy
por: Wu, Wen-an, et al.
Publicado: (2020)

Mapping of Regional Failures After Definitive Radiotherapy in Patients with Locally Advanced Cervical Esophageal Carcinoma
por: Zhao, Dan, et al.
Publicado: (2020)

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0o7ftjn1068d6gdusum2haj30g